MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Depression, anxiety and quality of life in Multiple System Atrophy

L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang (Chengdu, China)

Meeting: 2017 International Congress

Abstract Number: 175

Keywords: Anxiety, Depression, Multiple system atrophy(MSA): Clinical features

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To explore the features and determinants of depression and anxiety symptoms in multiple system atrophy (MSA) and the associations between mood dysfunction and quality of life (QOL) in MSA patients in Chinese population.

Background: Features and determinants of depression and anxiety symptoms in MSA and the associations between mood dysfunction and QOL in MSA patients in Chinese population remain unknown.

Methods: A total of 170 MSA patients were enrolled in the study. Neuropsychological assessment was performed using Hamilton Depression Rating Scale-24 items and Hamilton Anxiety Rating Scale. Parkinson’s Disease Questionnaire-39 item version was used to evaluate the QOL.

Results: We found that 64.1% and 71.7% patients had at least mild depression and anxiety symptoms, respectively. The severity of depression of MSA patients was associated with sex (P = 0.042), educational years (P = 0.030), disease duration (P = 0.001), disease severity (P = 0.007), orthostatic hypotension (P = 0.009) and global disability (P < 0.0001). While, the severity of anxiety was associated with increased disease duration (P < 0.0001), disease severity (UMSARS-I) (P = 0.020), orthostatic hypotension (P = 0.001) and global disability (P < 0.0001). Spearman’s correlation test showed both depression and anxiety symptoms had a close relationship with QOL in MSA patients. Binary logistic regression showed the determinants of depression were female, lower educational years, longer disease duration, orthostatic hypotension and global disability. Meanwhile, disease severity and orthostatic hypotension were the determinants of anxiety.

 

Conclusions: Depression and anxiety symptoms are common in patients with MSA. Both depression and anxiety symptoms have a close relationship with QOL in MSA patients. Neurologists should pay attention to depression and anxiety in patients with MSA, especially those with orthostatic hypotension and severe disease condition.

To cite this abstract in AMA style:

L. Zhang, B. Cao, Q. Wei, R. Ou, B. Zhao, J. Yang, Y. Wu, H. Shang. Depression, anxiety and quality of life in Multiple System Atrophy [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/depression-anxiety-and-quality-of-life-in-multiple-system-atrophy/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/depression-anxiety-and-quality-of-life-in-multiple-system-atrophy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley